Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review S Potvin, E Stip, AA Sepehry, A Gendron, R Bah, E Kouassi Biological psychiatry 63 (8), 801-808, 2008 | 1187 | 2008 |
Widespread and sustained cognitive deficits in alcoholism: a meta‐analysis K Stavro, J Pelletier, S Potvin Addiction biology 18 (2), 203-213, 2013 | 692 | 2013 |
Cannabidiol in humans—the quest for therapeutic targets S Zhornitsky, S Potvin Pharmaceuticals 5 (5), 529-552, 2012 | 313 | 2012 |
Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis S Potvin, J Pelletier, S Grot, C Hebert, AM Barr, T Lecomte Addictive behaviors 80, 154-160, 2018 | 286 | 2018 |
Antipsychotics' effects on blood levels of cytokines in schizophrenia: a meta-analysis V Tourjman, E Kouassi, ME Koue, M Rocchetti, S Fortin-Fournier, ... Schizophrenia research 151 (1-3), 43-47, 2013 | 255 | 2013 |
Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB MN Levaux, S Potvin, AA Sepehry, J Sablier, A Mendrek, E Stip European psychiatry 22 (2), 104-115, 2007 | 227 | 2007 |
Mobile apps for mental health issues: meta-review of meta-analyses T Lecomte, S Potvin, M Corbière, S Guay, C Samson, B Cloutier, ... JMIR mHealth and uHealth 8 (5), e17458, 2020 | 223 | 2020 |
Cocaine and cognition: a systematic quantitative review S Potvin, K Stavro, É Rizkallah, J Pelletier Journal of addiction medicine 8 (5), 368-376, 2014 | 217 | 2014 |
Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis S Potvin, CC Joyal, J Pelletier, E Stip Schizophrenia research 100 (1-3), 242-251, 2008 | 192 | 2008 |
Pain facilitation and pain inhibition during conditioned pain modulation in fibromyalgia and in healthy controls S Potvin, S Marchand Pain 157 (8), 1704-1710, 2016 | 169 | 2016 |
Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: a pilot clinical trial OP Du Sert, S Potvin, O Lipp, L Dellazizzo, M Laurelli, R Breton, ... Schizophrenia research 197, 176-181, 2018 | 168 | 2018 |
Human evidence of a supra‐spinal modulating role of dopamine on pain perception S Potvin, S Grignon, S Marchand Synapse 63 (5), 390-402, 2009 | 164 | 2009 |
The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms JB de Souza, S Potvin, P Goffaux, J Charest, S Marchand The Clinical journal of pain 25 (2), 123-127, 2009 | 160 | 2009 |
A meta-analysis of negative symptoms in dual diagnosis schizophrenia S Potvin, AA Sepehry, E Stip Psychological Medicine 36 (4), 431-440, 2006 | 144 | 2006 |
Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis. AA Sepehry, S Potvin, R Élie, E Stip Journal of Clinical Psychiatry 68 (4), 604-610, 2007 | 136 | 2007 |
Meta-analysis of rates of drop-out from psychosocial treatment among persons with schizophrenia spectrum disorder K Villeneuve, S Potvin, A Lesage, L Nicole Schizophrenia research 121 (1-3), 266-270, 2010 | 135 | 2010 |
Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder E Normand, S Potvin, I Gaumond, G Cloutier, JF Corbin, S Marchand The Journal of clinical psychiatry 71 (2), 13719, 2010 | 134 | 2010 |
Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study JB de Souza, P Goffaux, N Julien, S Potvin, J Charest, S Marchand Rheumatology International 29, 509-515, 2009 | 132 | 2009 |
Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies S Potvin, S Marchand Pain 138 (1), 70-78, 2008 | 131 | 2008 |
DRD3 Ser9Gly polymorphism is related to thermal pain perception and modulation in chronic widespread pain patients and healthy controls S Potvin, A Larouche, E Normand, JB de Souza, I Gaumond, S Grignon, ... The journal of pain 10 (9), 969-975, 2009 | 118 | 2009 |